Latest National Cancer Coalition Stories
RALEIGH, N.C., Dec. 14, 2012 /PRNewswire-USNewswire/ -- The National Cancer Coalition (NCC) is expanding its efforts to fight women's cancers in the developing world. NCC has pledged to increase its commitment to assist underserved women's cancer patients at-risk of breast, cervical or ovarian cancers. Helping over 10,000 women in their battle against cancer last year, the Coalition is transforming the lives of underserved women around the globe. "We have built a solid foundation...
RALEIGH, N.C., Dec. 26, 2011 /PRNewswire-USNewswire/ -- The National Cancer Coalition (NCC) is pleased to announce research grant recipients, which include: Peter C. Adamson, M.D., of Children's Hospital of Philadelphia; Debra L. Friedman, M.D., M.S. of Vanderbilt-Ingram Cancer Center; Thomas W. McLean, M.D. of Wake Forest University School of Medicine; Tobey J. MacDonald, M.D. of Emory University Cancer Center; Edward V. Prochownik, M.D., Ph.D. of Children's Hospital of...
RALEIGH, N.C., Sept. 13, 2011 /PRNewswire-USNewswire/ -- The National Cancer Coalition (NCC) is pleased to announce a $25,000 grant from the Bristol-Myers Squibb Foundation to support its women's cancer early detection program in Peru. The Bristol-Myers Squibb Foundation award is supporting a medical training program for Peruvian physicians and medical personnel, with an emphasis on prevention, early detection and treatment of cervical and breast cancers. National Cancer Coalition's...
RALEIGH, N.C., Feb. 4, 2011 /PRNewswire-USNewswire/ -- The National Cancer Coalition (NCC) and BD (Becton, Dickinson and Company), a leading global medical technology company, are pleased to announce the implementation of a cervical cancer early detection program to benefit 75,000 underserved women in Peru. With a goal to reduce the high cervical cancer mortality levels in the mountainous region surrounding Cusco, this extensive three-year program is set to conduct liquid-based cytology...
RALEIGH, N.C., May 24 /PRNewswire-USNewswire/ -- The National Cancer Coalition (NCC) is pleased to announce that it recently received a $25,000 grant award from the Hospira Foundation, the philanthropic arm of Hospira, Inc., to support its pharmaceutical relief program within the Dominican Republic. NCC is seeking to significantly increase the levels of medical resources that it provides to the public hospitals of the Dominican Republic in an effort to more fully treat the country's...
RALEIGH, N.C., Feb. 23 /PRNewswire-USNewswire/ -- The National Cancer Coalition (NCC) is pleased to announce its recent collaboration with Pfizer, Inc to provide hemophilia medicines to underserved patients in the developing world. To date, NCC has received more than 10 million international units of ReFacto® Antihemophilic Factor (Recombinant), a therapy used for the treatment and prevention of bleeding in people with hemophilia A, to assist patients who otherwise would have little...
RALEIGH, N.C., July 30 /PRNewswire-USNewswire/ -- The National Cancer Coalition (NCC) is pleased to announce its recent Angel Grant recipients, which include: Dr. Steven Brem of the H. Lee Moffitt Cancer Center, Dr. Julie Blatt of the University of North Carolina - Chapel Hill, Dr. Jeffrey Taub of the Children's Hospital of Michigan, and Dr. Eric Beyer of the University of Chicago. Steven S. Brem, M.D., is the Director of Neurosurgery and the Division Chief of the Neuro-Oncology Department...
LIMA, Peru, Jan. 14 /PRNewswire/ -- The National Cancer Coalition (NCC) and Wyeth Pharmaceuticals (Wyeth) are pleased to announce a pilot program to assist cancer patients in Latin America with donations of Wyeth's cancer-related medicines Mylotarg(TM) (gemtuzumab ozogamicin for injection) and Neumega(TM) (oprelvekin). United States Ambassador Michael McKinley and the Peruvian Health Ministry participated in a hand-over event held at the Instituto Nacional de Enfermadades Neoplacias...
